We are live on ! Find out more
CPC

Cookson Peirce & Co Portfolio holdings

AUM $3.04B
1-Year Est. Return 94.11%
This Fund
S&P 500
This Quarter Est. Return
+18.73%
1 Year Est. Return
+94.11%
3 Year Est. Return
+306.52%
5 Year Est. Return
+526.41%
10 Year Est. Return
+3,285.24%
AUM
$1.47B
AUM Growth
+$140M
Cap. Flow
-$18.2M
Cap. Flow %
-1.24%
Top 10 Hldgs %
33.28%
Holding
191
New
53
Increased
62
Reduced
37
Closed
37

Top Buys

Rank Stock Value
1
FCX icon
Freeport-McMoran
FCX
+$31.9M
2
PINS icon
Pinterest
PINS
+$27.2M
3
NVCR icon
NovoCure
NVCR
+$22.8M
4
INFY icon
Infosys
INFY
+$22.1M
5
DHI icon
D.R. Horton
DHI
+$18.6M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$43.4M
2
MCO icon
Moody's
MCO
+$43.1M
3
AKAM icon
Akamai
AKAM
+$42.5M
4
LLY icon
Eli Lilly
LLY
+$42.1M
5
DXCM icon
DexCom
DXCM
+$41M

Sector Composition

Rank Sector Weight
1 Technology 31.36%
2 Communication Services 15.59%
3 Consumer Discretionary 13.79%
4 Industrials 12.31%
5 Healthcare 12.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XLNX
151
DELISTED
Xilinx Inc
XLNX
$216K 0.01%
+1,521
New +$198K
ISRG icon
152
Intuitive Surgical
ISRG
$127B
$214K 0.01%
+783
New +$194K
AVGO icon
153
Broadcom
AVGO
$1.85T
$209K 0.01%
+4,770
New +$186K
HL icon
154
Hecla Mining
HL
$9.47B
$89K 0.01%
13,753
– –
AKAM icon
155
Akamai
AKAM
$16.7B
– –
-384,666
Closed -$42.5M
AMGN icon
156
Amgen
AMGN
$208B
– –
-1,595
Closed -$405K
AZN icon
157
AstraZeneca
AZN
$263B
– –
-89,220
Closed -$9.78M
BABA icon
158
Alibaba
BABA
$293B
– –
-681
Closed -$200K
BBY icon
159
Best Buy
BBY
$18.2B
– –
-2,365
Closed -$263K
BF.B icon
160
Brown-Forman Class B
BF.B
$13.2B
– –
-18,979
Closed -$1.43M
BX icon
161
Blackstone
BX
$102B
– –
-748,421
Closed -$39.1M
CHE icon
162
Chemed
CHE
$7.07B
– –
-5,640
Closed -$2.71M
DBEF icon
163
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.17B
– –
-6,945
Closed -$213K
DKNG icon
164
DraftKings
DKNG
$11.6B
– –
-20,400
Closed -$1.2M
DXCM icon
165
DexCom
DXCM
$32.2B
– –
-397,688
Closed -$41M
EA icon
166
Electronic Arts
EA
$53B
– –
-50,431
Closed -$6.58M
EQIX icon
167
Equinix
EQIX
$101B
– –
-16,588
Closed -$12.6M
ET icon
168
Energy Transfer Partners
ET
$70.1B
– –
-16,000
Closed -$87K
FTNT icon
169
Fortinet
FTNT
$119B
– –
-70,885
Closed -$1.67M
GIS icon
170
General Mills
GIS
$19.1B
– –
-149,981
Closed -$9.25M
HACK icon
171
Amplify Cybersecurity ETF
HACK
$2.68B
– –
-5,533
Closed -$258K
HD icon
172
Home Depot
HD
$331B
– –
-1,460
Closed -$405K
IBB icon
173
iShares Biotechnology ETF
IBB
$9.34B
– –
-2,418
Closed -$327K
LLY icon
174
Eli Lilly
LLY
$1.02T
– –
-284,273
Closed -$42.1M
MA icon
175
Mastercard
MA
$506B
– –
-13,981
Closed -$4.73M
4 5 6
7
8

Similar funds

MB
MUFG Bank Tokyo 100-8388,, Japan $3.04B AUM 15.55% 1-Year Est. Return
MCM
MKP Capital Management New York $3.04B AUM 20.46% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return
EP
Edgestream Partners Princeton, New Jersey $3.05B AUM 12.73% 1-Year Est. Return
SAG
Susquehanna Advisors Group Bala Cynwyd, Pennsylvania $3.05B AUM 41.49% 1-Year Est. Return
CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
CM
Castleark Management Chicago, Illinois $3.02B AUM 53.92% 1-Year Est. Return

Cookson Peirce & Co's Q4 2020 Portfolio in Review

As of Q4 2020, Cookson Peirce & Co held 191 positions worth $1.47B, up 11% from $1.33B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Cookson Peirce & Co's Q4 2020 filing shows 53 new, 62 increased, 37 reduced and 37 closed positions. Its largest new stake was Freeport-McMoran: 1,533,470 shares worth $39.9M. The largest sale was Vertex Pharmaceuticals, an estimated $43.4M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • Cookson Peirce & Co's largest Q4 2020 buy was Freeport-McMoran: 1,533,470 shares worth $39.9M.
  • Cookson Peirce & Co added most to NovoCure in Q4 2020, an estimated $22.8M increase.
  • Cookson Peirce & Co's biggest Q4 2020 reduction was Insulet, cutting an estimated $1.59M.
  • Cookson Peirce & Co fully exited Vertex Pharmaceuticals in Q4 2020, selling an estimated $43.4M.
  • Cookson Peirce & Co's ten largest holdings make up 33% of its $1.47B portfolio in Q4 2020.
  • Cookson Peirce & Co opened 53 new positions and closed 37 in Q4 2020.
  • Cookson Peirce & Co's portfolio value rose 11% quarter-over-quarter to $1.47B.

Based on Cookson Peirce & Co's 13F filing for Q4 2020, filed 10 Feb 2021.